// company-profile

Dermata Therapeutics, Inc. Insider Trading

DRMA

Every SEC Form 4 insider trading filing for Dermata Therapeutics, Inc. (DRMA) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings41Insiders11
// api This Dermata Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=DRMA" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Dermata Therapeutics, Inc. insiders sold $13 across 1 transaction with no open-market purchases.

  • Most active insider: Scott Kathleen D. with 1 transaction totaling $13.
  • Largest single sale: $13 by Scott Kathleen D. on Jun 16, 2026.

Activity skews bearish — sales outpace buys.

Institutional Ownership

Top 13F-HR holders of Dermata Therapeutics, Inc. as of 2026-06-30

— stable
Total reported AUM
$50,148
QoQ change
Reporting period
2026-06-30
#1
Welch & Forbes LLC
CIK 105495
$25,800
20K shares
#2
STATE STREET CORP
CIK 93751
$24,184
19K shares
#3
SBI Securities Co., Ltd.
CIK 1851815
$130
101 shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026Scott Kathleen D.DRMA
Sale
11$1.19$0K
Feb 17, 2026Bedoya-Toro Munera Maria EDRMA
Purchase
1,000$1.27$1K
Jan 2, 2026Sandler Andrew SethDRMA
Award
2,500$0.00$0K
Jan 2, 2026FISHER MARYDRMA
Award
2,500$0.00$0K
Jan 2, 2026WIERENGA WENDELLDRMA
Award
2,500$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →